Public Health Significance India has one of the largest populations of diabetics and a rapidly rising obesity burden
Additionally, per publicly available FDA and manufacturer announcements, orforglipron (Eli Lilly's Foundayo, a non-peptide oral GLP-1 receptor agonist) received FDA approval on April 1, 2026 for chronic weight management
The half-life of retatrutide is approximately six days, achieved through acylation with a fatty diacid moiety
Two Approvals, Four Months Apart The FDA approved the oral Wegovy pill (once-daily oral semaglutide 25mg) in December 2025
From my perspective as a fellow manufacturer in the skincare industry, what immediately catches my attention is how strongly iCare structures its entire business around removing friction from the launch process
80 PezeshkpourG.IllaI.DalakasM